Malignant lymphoma. 1.
D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects; D003095:Collagen Diseases / Q000150:complications; D004854:Herpesvirus 4, Human; D006689:Hodgkin Disease / Q000145:classification / Q000453:epidemiology / Q000209:etiology / Q000473:pathology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007945:Leukemia, Lymphoid / Q000209:etiology / Q000662:veterinary; D008223:Lymphoma / Q000139:chemically induced / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000662:veterinary; D009858:Oncogenic Viruses; D012328:RNA Viruses; D013601:T-Lymphocytes / Q000276:immunology
D000927:Anticonvulsants; D007166:Immunosuppressive Agents